April 22, 2024

The Activator | In-Person Info session (Heidelberg)

The Activator | In-Person Info session (Heidelberg)

We invite you to our in-person info session in Heidelberg (at BioLabs – tour included!) to learn more about Nucleate’s Activator program! Hear from the leadership team about how Nucleate can help kickstart your life science venture.

​​​​​Our Impact:

​​​​Over the past 5 years, Nucleate has supported >400 venture teams, with our alumni raising over $370M USD to develop cutting-edge technologies like protein sequencing (Glyphic Biotechnologies), drug design (Manifold Bio), microbe-based therapeutics (Concerto Biosciences), and RNA-based therapeutics (NextRNA Therapeutics).

​​​​​Application Process:

​​​​🧬 Bio Track – for innovators in therapeutics, diagnostics, or tools.

​​​​🌿 Eco Track – sustainable food & agriculture, chemicals & energy, or consumer products, climate tech

Don’t have an idea yet? Join a team as a scientific, business, or clinical contributor through our matching process.

​​​​​About Nucleate:

​​​​Nucleate is a global nonprofit organization dedicated to empowering tomorrow’s biotech leaders by educating today’s academic trainees. With a network spanning 28 chapters and encompassing over 150 academic institutions worldwide, Nucleate is supported by a passionate cohort of over 1000 student leaders who are dedicated to identifying and nurturing future biotech trailblazers.

Learn more before the event here: https://nucleate.org/activator/

Ort
BioLabs Heidelberg (BioLabs Coworking Space GmbH)
Nikola-Tesla-Straße, 69124 Heidelberg, Germany
register now

Our latest News

discover more
Christiane Herzog Foundation honors cystic fibrosis facilities at Heidelberg University Hospital

Christiane Herzog Foundation honors cystic fibrosis facilities at Heidelberg University Hospital

The Christiane Herzog Foundation has honored the Cystic Fibrosis Center at the Center for Pediatric and Adolescent Medicine and the Cystic Fibrosis Outpatient Clinic at the Thorax Clinic as the “Christiane Herzog Center.” With this award, the foundation recognizes the exceptional commitment and high level of expertise in the care of patients with cystic fibrosis […]

Heidelberg neurologist and neuroscientist becomes new member of the EMBO Young Investigator Program

Heidelberg neurologist and neuroscientist becomes new member of the EMBO Young Investigator Program

Dr. Varun Venkataramani, Heidelberg Medical Faculty of Heidelberg University and German Cancer Research Center, discovered that nerve cells in the brain come into contact with tumor cells, thereby significantly promoting the growth of highly aggressive glioblastomas. In doing so, he laid the groundwork for the new field of research known as “cancer neuroscience.” The European […]

VIRE: a global data platform to better understand viruses

VIRE: a global data platform to better understand viruses

Researchers release a comprehensive viral genome database covering diverse ecosystems to advance understanding of viral evolution and ecosystem functions Summary Researchers have developed VIRE, a database that integrates approximately 1.7 million viral genomes derived from more than 100,000 metagenomes worldwide. Metagenomic data is obtained by comprehensively sequencing all DNA present in an environment. This approach enables […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp